Cross SS - Search Results

1

Endostatin gene variation and protein levels in breast cancer susceptibility and severity.

Balasubramanian SP, Cross SS, Globe J, Cox A, Brown NJ, Reed MW. Balasubramanian SP, et al. Among authors: cross ss. BMC Cancer. 2007 Jun 22;7:107. doi: 10.1186/1471-2407-7-107. BMC Cancer. 2007. PMID: 17587451 Free PMC article.

2

Ownership and uses of human tissue: does the Nuffield bioethics report accord with opinion of surgical inpatients?

Start RD, Brown W, Bryant RJ, Reed MW, Cross SS, Kent G, Underwood JC. Start RD, et al. Among authors: cross ss. BMJ. 1996 Nov 30;313(7069):1366-8. doi: 10.1136/bmj.313.7069.1366. BMJ. 1996. PMID: 8956702 Free PMC article.

3

Angiogenesis induction and regression in human surgical wounds.

Brown NJ, Smyth EA, Cross SS, Reed MW. Brown NJ, et al. Among authors: cross ss. Wound Repair Regen. 2002 Jul-Aug;10(4):245-51. doi: 10.1046/j.1524-475x.2002.10408.x. Wound Repair Regen. 2002. PMID: 12191007

4

Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing.

Gillard JA, Reed MW, Buttle D, Cross SS, Brown NJ. Gillard JA, et al. Among authors: cross ss. Wound Repair Regen. 2004 May-Jun;12(3):295-304. doi: 10.1111/j.1067-1927.2004.012314.x. Wound Repair Regen. 2004. PMID: 15225208

5

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?

Holen I, Cross SS, Neville-Webbe HL, Cross NA, Balasubramanian SP, Croucher PI, Evans CA, Lippitt JM, Coleman RE, Eaton CL. Holen I, et al. Among authors: cross na, cross ss. Breast Cancer Res Treat. 2005 Aug;92(3):207-15. doi: 10.1007/s10549-005-2419-8. Breast Cancer Res Treat. 2005. PMID: 16155791

6

Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?

Cross SS, Yang Z, Brown NJ, Balasubramanian SP, Evans CA, Woodward JK, Neville-Webbe HL, Lippitt JM, Reed MW, Coleman RE, Holen I. Cross SS, et al. Int J Cancer. 2006 Apr 15;118(8):1901-8. doi: 10.1002/ijc.21606. Int J Cancer. 2006. PMID: 16287088

7

Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.

Cross SS, Harrison RF, Balasubramanian SP, Lippitt JM, Evans CA, Reed MW, Holen I. Cross SS, et al. J Clin Pathol. 2006 Jul;59(7):716-20. doi: 10.1136/jcp.2005.030031. Epub 2006 Feb 17. J Clin Pathol. 2006. PMID: 16489180 Free PMC article.

8

Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review.

Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, Brown NJ, Reed MW. Balasubramanian SP, et al. Among authors: cross ss. BMC Cancer. 2006 Jul 14;6:188. doi: 10.1186/1471-2407-6-188. BMC Cancer. 2006. PMID: 16842617 Free PMC article.

9

Promoter hypermethylation identifies progression risk in bladder cancer.

Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JW. Yates DR, et al. Among authors: cross ss. Clin Cancer Res. 2007 Apr 1;13(7):2046-53. doi: 10.1158/1078-0432.CCR-06-2476. Clin Cancer Res. 2007. PMID: 17404085 Free article.

10

Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity.

Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW. Balasubramanian SP, et al. Among authors: cross ss. Int J Cancer. 2007 Sep 1;121(5):1009-16. doi: 10.1002/ijc.22772. Int J Cancer. 2007. PMID: 17471570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters